5 Revealing Analyst Questions From Novanta’s Q2 Earnings Call
$1000 Invested In Novanta 15 Years Ago Would Be Worth This Much Today
Novanta (NOVT) Q2 2026 Earnings Call Transcript
Are You Looking for a Top Momentum Pick? Why Novanta (NOVT) is a Great Choice
NOVT Q2 Deep Dive: Acquisition and Manufacturing Moves Drive Outlook Higher
Novanta (NOVT) Lifted Guidance And Closed Riverpoint, Is The Upside Already Priced In?
Novanta (NOVT) Closes Its Largest Acquisition】【。
Novanta Inc (NOVT) (Q2 2026) Earnings Call Highlights: Record Cash Flow and Raised Guidance ...
Novanta Q2 Earnings Call Highlights
Increased Bookings Reinforce Novanta’s (NOVT) Broadening Organic Momentum
Novanta (NOVT) Tops Q2 Earnings and Revenue Estimates
Novanta’s (NASDAQ:NOVT) Q2 CY2026 Sales Top Estimates, Guides for Strong Full-Year Sales
Novanta Announces Financial Results for the Second Quarter 2026
Novanta Raises FY2026 Adj EPS Guidance from $3.50-$3.65 to $3.68-$3.74 vs $3.59 Est; Raises FY2026 Sales Guidance from $1.040B-$1.055B to $1.130B-$1.140B vs $1.053B Est
Novanta Sees Q3 Adj EPS $0.95-$1.00 vs $0.94 Est; Sees Sales $300.000M-$304.000M vs $262.827M Est
Novanta Q2 Adj. EPS $0.89 Beats $0.83 Estimate, Sales $265.807M Beat $262.297M Estimate
Will Novanta (NOVT) Beat Estimates Again in Its Next Earnings Report?
Novanta (NOVT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Novanta Completes Acquisition of Riverpoint Medical
3 Reasons to Avoid NOVT and 1 Stock to Buy Instead
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.